Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa, Koshi Nakamura, Takafumi Nakagawa, Yasuo Terauchi, Akiko Tamakoshi, Tatsuya Atsumi
Correlation between serum proinsulin levels and fatty liver: the DOSANCO Health Study
Journal of Diabetes Investigation, in press.
IF: 3.902
Lee WS, Yasuda S, Kono M, Kudo Y, Shimamura S, Kono M, Fujieda Y, Kato M, Oku K, Shimizu T, Onodera T, Iwasaki N and Atsumi T.
MicroRNA-9 Ameliorates Destructive Arthritis through Down-regulation of NF-κB1-RANKL Pathway in Fibroblast-like Synoviocytes Clinical Immunology IF 3.548
Kameda R, Nomoto H, Cho KY, Kawata S, Omori K, Takeuchi J, Nagai S, Kurihara Y, Aoki S, Nakamura A, Atsumi T, Miyoshi H.
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicenter, prospective, randomized, open-label, blinded endpoint parallel-group comparison study.
BMJ Open. 2020
Nakamura A, Miyoshi H, Kameda H, Yamashita K, Kurihara Y.
Impact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria
Diabetol Metab Syndr. 2020.
Nakamura H, Fujieda Y, Tarumi M, Kitakawa H, Hisada R, Nakagawa I, Noguchi A, Kurita T, Kataoka H, Kasahara H, Amasaki Y, Yokota I,
Atsumi T
Calcineurin Inhibitors for Adult-Onset Still’s Disease: A Multi-Center Epidemiological Study
Clin Exp Rheumatol
IF: 3.238
Wen Shi Lee and Olga Amengual.
Cells targeting therapy in the management of systemic lupus erythematosus.
Immunological Medicine.
Accepted 25 November,2019 in press
Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Kudo T, Hattanda F, Nishio S, Masuda S, Tomaru U, Kondo T, Atsumi T, Ishizu A.
Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Journal of Autoimmunity. 2019. PMID: 31883830
Maeda T, Kitamura S, Yanagi T, Narahira A, Miyamoto K, Hata H, Cho KY, Kameda H, Nakamura A, Shimizu H.
Type 1 diabetes mellitus in a melanoma patient treated with adjuvant nivolumab therapy.
Journal of Cutaneous Immunology and Allergy. 2019.